Dr. Jeffrey Probstfield

Related by string. * Drs . dr . DRS . DR . DRD . Dring . DRs : Dr Manmohan Singh . Dred Scott decision . Dr. Martin Luther . Dr. Anne Schuchat . Dr BR Ambedkar . Dr. Reddy Laboratories . DEAR DR / jeffrey . Jeffreys . JEFFREYS . JEFFREY : Chief Executive Jeffrey Skilling . CEO Jeffrey Skilling . President Jeffrey Lacker . Jeffrey Skilling . Jeffrey Lacker . Jeffrey Rein . whistleblower Jeffrey Wigand / : Probstfield * *

Related by context. Frequent words. (Click for all words.) 54 phase IIa clinical 51 double blinded randomized 51 olaparib 51 placebo controlled clinical 51 phase IIb clinical 51 Randomized controlled 51 SPIRIT IV 50 ABSORB trial 50 ataluren 50 Prostate Cancer Prevention 49 CALGB 49 ONTARGET 49 neuropharmacology 49 TAXUS IV 49 Cedric Garland 48 Prostate Lung Colorectal 48 David Rudovsky 48 Pericak Vance 48 Canvaxin 48 SPIRIT III 48 SWOG 47 urologic oncology 47 dose escalation clinical 47 multicenter clinical 47 ganetespib 47 RE LY 47 NSABP 47 elotuzumab 47 SCD HeFT 47 recurrent glioblastoma multiforme 46 phase IIa 46 NanoBio Corporation 46 pertuzumab 46 Agios Pharmaceuticals 46 AVADO 46 TACI Ig 46 MD Dr.PH 46 Phase Ib clinical 46 Jonsson Comprehensive Cancer 46 iniparib 46 researcher Hwang Woo 46 Kevin Eggan 45 EVEREST II 45 telcagepant 45 teriflunomide 45 Phase Ib II 45 Duke Comprehensive Cancer 45 Dr. Shinya Yamanaka 45 Regado Biosciences 45 Elias Zerhouni 45 Rush Alzheimer Disease 45 bronchial thermoplasty 45 TRITON TIMI 45 Neurochemistry 45 Maxine Waters D Calif 45 MD DrPH 45 Microbiology Immunology 45 INTERCEPT red 45 Johns Hopkins Kimmel 45 tanespimycin 45 Phase 2a clinical 45 cilostazol 44 NCCTG 44 randomized controlled clinical 44 gene therapy 44 deadlocked juries 44 Cancer Immunotherapy 44 blinded placebo controlled 44 biochemistry molecular biology 44 Geron Corp. 44 phase Ib 44 Multicenter 44 Asentar 44 Lycera 44 ocrelizumab 44 urologic surgery 44 SUCCEED trial 44 Randomised 44 HPTN 44 trials 44 TOLAMBA 44 Neurotrauma 44 Zilver PTX 44 Pervasis 44 KRN# 43 Phase 2a trial 43 MD M.Sc. 43 iPrEx 43 Slone Epidemiology Center 43 metastatic castration resistant 43 blind randomized controlled 43 senicapoc 43 rufinamide 43 LibiGel Phase III 43 CHAVI 43 scientist Alan Abramowitz 43 Phase IIa clinical 43 Brain Behavior 43 randomized controlled clinical trials 43 multicenter prospective 43 TGN#

Back to home page